Guided Therapeutics (GTHP) Other financing activities (2021 - 2025)

Guided Therapeutics' Other financing activities history runs 4 years deep, the most recent figure standing at -$32000.0 for Q4 2025.

• In Q4 2025, Other financing activities changed N/A year-over-year to -$32000.0; the TTM figure through Dec 2025 stood at -$33000.0 (down 3200.0% YoY), while the FY2025 annual figure was $30000.0, up 3.45% from the prior year.
• Other financing activities came in at -$32000.0 for Q4 2025 at Guided Therapeutics, down from -$31000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $722000.0 in Q3 2022 to a low of -$722000.0 in Q4 2022.
• A 4-year average of $4833.3 and a median of -$500.0 in 2024 frame the typical range for Other financing activities.
• On a YoY basis, Other financing activities climbed as much as 1064.52% in 2022 and fell as far as 1064.52% in 2022.
• Guided Therapeutics' Other financing activities stood at $62000.0 in 2021, then slumped by 1264.52% to -$722000.0 in 2022, then jumped by 95.71% to -$31000.0 in 2024, then slipped by 3.23% to -$32000.0 in 2025.
• According to Business Quant data, Other financing activities over the past three periods registered -$32000.0, -$31000.0, and $30000.0 for Q4 2025, Q3 2024, and Q2 2024 respectively.

Peer Comparison